2016 Q1 Form 10-K Financial Statement

#000101008616000019 Filed on March 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015
Revenue $1.300M $4.200M $8.200M
YoY Change 8.33% 425.0% 164.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.656M $2.568M $10.58M
YoY Change -13.99% 5.98% -16.33%
% of Gross Profit
Research & Development $2.536M $4.934M $13.13M
YoY Change -9.78% 69.96% 22.63%
% of Gross Profit
Depreciation & Amortization $44.45K $50.00K $247.4K
YoY Change -43.57% -37.5% -29.64%
% of Gross Profit
Operating Expenses $8.329M $7.502M $39.13M
YoY Change 33.66% 40.86% -81.61%
Operating Profit -$7.059M -$17.95M -$30.95M
YoY Change 40.06% 2.27% -85.24%
Interest Expense $0.00 $0.00 $266.7K
YoY Change -100.0% -100.0% -41.48%
% of Operating Profit
Other Income/Expense, Net $11.31K $0.00 $42.20K
YoY Change 107.01% 3862.63%
Pretax Income $10.40M -$19.90M -$38.99M
YoY Change 46.48% 2.05% -81.6%
Income Tax $11.29K $200.0K $462.0K
% Of Pretax Income 0.11%
Net Earnings -$10.45M -$20.09M -$39.45M
YoY Change 46.08% 5.45% -85.14%
Net Earnings / Revenue -803.77% -478.43% -481.11%
Basic Earnings Per Share -$0.73
Diluted Earnings Per Share -$192.2K -$371.5K -$0.73
COMMON SHARES
Basic Shares Outstanding 54.11M shares 54.11M shares 53.78M shares
Diluted Shares Outstanding 53.78M shares

Balance Sheet

Concept 2016 Q1 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.1M $112.7M $112.7M
YoY Change 9.01% 13.04% 13.04%
Cash & Equivalents $104.1M $112.7M $112.7M
Short-Term Investments
Other Short-Term Assets $600.0K $600.0K $600.0K
YoY Change -91.04% -94.34% -94.34%
Inventory $22.84M $12.45M $12.40M
Prepaid Expenses
Receivables $1.003M $3.677M $3.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $128.5M $129.5M $129.5M
YoY Change -2.17% 4.28% -0.23%
LONG-TERM ASSETS
Property, Plant & Equipment $413.8K $449.8K $400.0K
YoY Change -45.05% -45.93% -50.0%
Goodwill $898.3K $898.3K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.990M $1.990M $54.90M
YoY Change 0.0% 0.0% 57.31%
Total Long-Term Assets $56.34M $56.27M $56.20M
YoY Change 34.36% 53.84% 53.55%
TOTAL ASSETS
Total Short-Term Assets $128.5M $129.5M $129.5M
Total Long-Term Assets $56.34M $56.27M $56.20M
Total Assets $184.8M $185.7M $185.7M
YoY Change 6.67% 15.56% 11.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.494M $3.944M $3.900M
YoY Change 139.04% 16.55% 14.71%
Accrued Expenses $5.045M $3.389M $3.400M
YoY Change 47.36% 62.45% 61.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $13.54M $7.333M $7.300M
YoY Change 94.05% -1.7% -2.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $465.7M $462.6M $462.6M
YoY Change 12.76% 15.79% 15.79%
Total Long-Term Liabilities $465.7M $462.6M $462.6M
YoY Change 12.76% 15.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.54M $7.333M $7.300M
Total Long-Term Liabilities $465.7M $462.6M $462.6M
Total Liabilities $479.5M $470.2M $470.2M
YoY Change 12.44% 15.45% 13.88%
SHAREHOLDERS EQUITY
Retained Earnings -$471.9M -$461.4M
YoY Change 9.96% 9.35%
Common Stock $177.2M $177.0M
YoY Change 0.72% 0.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$294.7M -$284.4M -$284.4M
YoY Change
Total Liabilities & Shareholders Equity $184.8M $185.7M $185.7M
YoY Change 6.67% 15.56% 11.6%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$10.45M -$20.09M -$39.45M
YoY Change 46.08% 5.45% -85.14%
Depreciation, Depletion And Amortization $44.45K $50.00K $247.4K
YoY Change -43.57% -37.5% -29.64%
Cash From Operating Activities -$8.641M -$16.52M $11.11M
YoY Change 40.09% 270.4% -21.64%
INVESTING ACTIVITIES
Capital Expenditures $8.475K -$50.00K $109.0K
YoY Change 288.48%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$4.000M
YoY Change -100.0% -200.0%
Cash From Investing Activities -$8.475K -$50.00K $3.891M
YoY Change -100.21% -212.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $0.00 $2.000M
YoY Change -100.0% 0.0%
Cash From Financing Activities $0.00 -10.00K -$2.003M
YoY Change -100.0% -98.0% -13.42%
NET CHANGE
Cash From Operating Activities -$8.641M -16.52M $11.11M
Cash From Investing Activities -$8.475K -50.00K $3.891M
Cash From Financing Activities $0.00 -10.00K -$2.003M
Net Change In Cash -$8.650M -16.58M $13.00M
YoY Change 107.51% 234.27% 54.65%
FREE CASH FLOW
Cash From Operating Activities -$8.641M -$16.52M $11.11M
Capital Expenditures $8.475K -$50.00K $109.0K
Free Cash Flow -$8.650M -$16.47M $11.00M
YoY Change 40.23% 269.28% -22.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54114296 shares
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
69457527 USD
CY2015 dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Trading Symbol
TradingSymbol
SIGA
CY2015Q4 siga Amount To Be Paid On Effective Dateof Plan Of Reorganization
AmountToBePaidOnEffectiveDateofPlanOfReorganization
5000000 USD
CY2015Q4 siga Bankruptcyclaimsallotherliquidatedproofofclaims
Bankruptcyclaimsallotherliquidatedproofofclaims
3037125 USD
CY2013 siga Change In Excess Tax Benefit Stock Based Compensation Financing Activities
ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities
-23668 USD
CY2015 siga Deferred Tax Assts Operating Loss Carryforwards Subjectto Limitations
DeferredTaxAsstsOperatingLossCarryforwardsSubjecttoLimitations
1800000 USD
CY2014Q4 siga Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
11667663 USD
CY2015Q4 siga Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
18922571 USD
CY2013 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
-0.001
CY2014 siga Change In Excess Tax Benefit Stock Based Compensation Financing Activities
ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities
0 USD
CY2015 siga Change In Excess Tax Benefit Stock Based Compensation Financing Activities
ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities
15531 USD
CY2013 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
73756 USD
CY2014 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-313425 USD
CY2015Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-129398 USD
CY2015Q3 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-184027 USD
CY2015 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
0 USD
CY2015Q4 siga Collateral
Collateral
0.50
CY2014Q4 siga Computer Equipment
ComputerEquipment
669782 USD
CY2015Q4 siga Computer Equipment
ComputerEquipment
754502 USD
CY2011Q2 siga Contract Value Detail Of Option Exercisable Development Activities
ContractValueDetailOfOptionExercisableDevelopmentActivities
58300000 USD
CY2011Q2 siga Contract Value Detail Of Option Exercisable Production Activities
ContractValueDetailOfOptionExercisableProductionActivities
14400000 USD
CY2011Q2 siga Contract Value Option Fda Approval
ContractValueOptionFDAApproval
50000000 USD
CY2011Q2 siga Contract Valueof Various Options
ContractValueofVariousOptions
122700000 USD
CY2015 siga Courses Delivered Provisional Dosage Twice Daily
CoursesDeliveredProvisionalDosageTwiceDaily
383754 course
CY2014 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.000
CY2015 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.000
CY2013 siga Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
0.000
CY2014 siga Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
-0.004
CY2015 siga Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
-0.070
CY2014 siga Expenseof Warrants Heldas Assets
ExpenseofWarrantsHeldasAssets
136364 USD
CY2015 siga Expenseof Warrants Heldas Assets
ExpenseofWarrantsHeldasAssets
45456 USD
CY2015Q4 siga Final Order And Judgment
FinalOrderAndJudgment
205000000 USD
CY2015Q1 siga Final Order And Judgment
FinalOrderAndJudgment
195000000 USD
CY2015Q4 siga Final Order And Judgment Preand Post Judgment Interest
FinalOrderAndJudgmentPreandPostJudgmentInterest
205400000 USD
CY2015 siga Government Contract Numberof Free Courses Deliveredand Accepted
GovernmentContractNumberofFreeCoursesDeliveredandAccepted
259200 course
CY2013 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
73756 USD
CY2014 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-313425 USD
CY2015 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
0 USD
CY2014 siga Inventory Write Downs
InventoryWriteDowns
1000000 USD
CY2015 siga Inventory Write Downs
InventoryWriteDowns
60000 USD
CY2014Q4 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
3502607 USD
CY2015Q4 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
834219 USD
CY2014Q4 siga Liabilitiessubjecttocompromisedeferredrevenue
Liabilitiessubjecttocompromisedeferredrevenue
203696194 USD
CY2015Q4 siga Liabilitiessubjecttocompromisedeferredrevenue
Liabilitiessubjecttocompromisedeferredrevenue
0 USD
CY2014Q4 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3200000 USD
CY2015Q4 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3200000 USD
CY2014Q4 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
794750 USD
CY2015Q4 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
737883 USD
CY2015Q4 siga Net Capital Deficiency
NetCapitalDeficiency
284000000 USD
CY2015 siga Number Of Active Contracts
NumberOfActiveContracts
1 contract
CY2015 siga Number Of Active Grants
NumberOfActiveGrants
1 grant
CY2012 siga Loan Term
LoanTerm
P3Y
CY2014Q4 siga Loss Accrual Expectation Damages
LossAccrualExpectationDamages
187820361 USD
CY2014 siga Loss On Disposal Of Assets
LossOnDisposalOfAssets
0 USD
CY2015 siga Loss On Disposal Of Assets
LossOnDisposalOfAssets
-243707 USD
CY2013 siga Patent Preparation Fees
PatentPreparationFees
1421218 USD
CY2014Q1 siga Patent Preparation Fees
PatentPreparationFees
286000 USD
CY2014Q2 siga Patent Preparation Fees
PatentPreparationFees
226000 USD
CY2014Q3 siga Patent Preparation Fees
PatentPreparationFees
306000 USD
CY2014Q4 siga Patent Preparation Fees
PatentPreparationFees
170000 USD
CY2014 siga Patent Preparation Fees
PatentPreparationFees
987777 USD
CY2015Q1 siga Patent Preparation Fees
PatentPreparationFees
333000 USD
CY2015Q2 siga Patent Preparation Fees
PatentPreparationFees
235000 USD
CY2015Q3 siga Patent Preparation Fees
PatentPreparationFees
194000 USD
CY2015Q4 siga Patent Preparation Fees
PatentPreparationFees
246000 USD
CY2015 siga Patent Preparation Fees
PatentPreparationFees
1009053 USD
CY2015Q4 siga Payment To Extend Days To Satisfy Claim
PaymentToExtendDaysToSatisfyClaim
20000000 USD
CY2015Q4 siga Payment To Post Collateral For Surety Bond
PaymentToPostCollateralForSuretyBond
1300000 USD
CY2015Q4 siga Potential Future Aggregate Research And Development Expenses
PotentialFutureAggregateResearchAndDevelopmentExpenses
7200000 USD
CY2013 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
2868387 USD
CY2014 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
102035 USD
CY2015 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
12200 USD
CY2015Q1 siga Proof Of Claim Asserted In Connection With Litigation
ProofOfClaimAssertedInConnectionWithLitigation
194649042 USD
CY2014Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2015Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2013 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
751370 USD
CY2014 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
0 USD
CY2015 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
0 USD
CY2013 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1400000 USD
CY2014 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1600000 USD
CY2015 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1400000 USD
CY2014 siga Reorganization Payments
ReorganizationPayments
1500000 USD
CY2015 siga Reorganization Payments
ReorganizationPayments
6700000 USD
CY2014 siga Reorganization Professional Fees
ReorganizationProfessionalFees
225360 USD
CY2015 siga Reorganization Professional Fees
ReorganizationProfessionalFees
2027827 USD
CY2014 siga Reorganization Trusteefees
ReorganizationTrusteefees
17875 USD
CY2015 siga Reorganization Trusteefees
ReorganizationTrusteefees
59000 USD
CY2013 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
5519300 USD
CY2014Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
549000 USD
CY2014Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
651000 USD
CY2014Q3 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1099000 USD
CY2014Q4 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
840000 USD
CY2014 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
3139835 USD
CY2015Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1192000 USD
CY2015Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1467000 USD
CY2015Q3 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1327000 USD
CY2015Q4 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
4189000 USD
CY2015 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
8175878 USD
CY2015 siga Researchand Development Revenue Longterm Contract
ResearchandDevelopmentRevenueLongtermContract
6200000 USD
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
271000 USD
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
227863 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3497251 USD
CY2013 siga Revenue Percentage
RevenuePercentage
1
CY2014 siga Revenue Percentage
RevenuePercentage
1
CY2015 siga Revenue Percentage
RevenuePercentage
1.00
CY2014Q4 siga Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber
500000 shares
CY2015Q4 siga Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber
500000 shares
CY2015Q4 siga Suretybond
Suretybond
2700000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3384310 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3944476 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
491632 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3676730 USD
CY2014Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
17500 USD
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
580801 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2085995 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3388608 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
534775 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
597721 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3299417 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
175483180 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177008371 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2172597 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2299098 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1528582 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1600000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2400000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000 USD
CY2014Q4 us-gaap Assets
Assets
160729407 USD
CY2015Q4 us-gaap Assets
Assets
185732936 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
124148743 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
129458829 USD
CY2015Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
110000000 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32017490 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91309754 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99713929 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112711028 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
59292264 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8404175 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12997099 USD
CY2014Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
4000000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53504296 shares
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
639576 USD
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
662011 USD
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54114296 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53504296 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54114296 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5351 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5411 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1608033 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-10428 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
439934 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1981488 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-40803 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
440880 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
373455 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-30375 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
946 USD
CY2012Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5000000 USD
CY2014Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2000000 USD
CY2014 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
1806701 USD
CY2015 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
5719052 USD
CY2014 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
76600 USD
CY2015 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
5672 USD
CY2014Q4 us-gaap Deferred Costs
DeferredCosts
32860874 USD
CY2015Q4 us-gaap Deferred Costs
DeferredCosts
52936428 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-10072499 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
53198632 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
19006 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9599927 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
53569071 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21103 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
81799 USD
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
255258371 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
472572 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
370439 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2097 USD
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
37910548 USD
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
59892477 USD
CY2014Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1106235 USD
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
887906 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
144245689 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
162677117 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11667663 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19154448 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30402940 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22701028 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
777804 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.014
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
1578816 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
2034283 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2389811 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1947019 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
67833412 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
73421980 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
132578026 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
143522669 USD
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
244540 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
265643 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
-1606547 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
-1130413 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
244540 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
267598 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
244540 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
265643 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
229922 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
463137 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
351561 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
247357 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.97
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.49
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.97
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.253
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.006
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.597
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.278
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.004
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.029
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.002
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
488807 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
452696 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
345658 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
345658 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2014Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2015Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24795772 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-211934870 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38989341 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7618439 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53528268 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
461983 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4566993 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4436468 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1862779 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3759484 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-490391 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3185098 USD
CY2013 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
19741668 USD
CY2014 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
10277672 USD
CY2015 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
20075554 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
105170169 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-162140390 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
255176572 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2873427 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1470872 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6597389 USD
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-147621 USD
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-43186 USD
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
281302 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-42280 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-73107 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-188101 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
236134 USD
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-229266 USD
CY2013 us-gaap Interest Expense
InterestExpense
1207332 USD
CY2014 us-gaap Interest Expense
InterestExpense
455810 USD
CY2015 us-gaap Interest Expense
InterestExpense
266726 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2355795 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 USD
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3170598 USD
CY2015Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2542044 USD
CY2014Q4 us-gaap Liabilities
Liabilities
407231884 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
272729 USD
CY2015Q4 us-gaap Liabilities
Liabilities
470161486 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
160729407 USD
CY2015Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
12447088 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
19044477 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
12447088 USD
CY2014Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
16688682 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185732936 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-39451324 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1497 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1065 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42202 USD
CY2014Q2 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
51000 USD
CY2014Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
175466000 USD
CY2014Q4 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
12899000 USD
CY2014 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
188465065 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7460253 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7333084 USD
CY2014Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
399039967 USD
CY2015Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
206972170 USD
CY2013 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
0 USD
CY2014 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
399039967 USD
CY2015 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
-192067797 USD
CY2012Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7000000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1989948 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2012Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.0985
CY2014Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
191046416 USD
CY2015Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
205400000 USD
CY2015Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
205400068 USD
CY2013 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
197207 USD
CY2014Q1 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
49000 USD
CY2015Q1 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2015Q2 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2015Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
14000 USD
CY2015Q4 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
14394000 USD
CY2015 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
14407494 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1713103 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2313906 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2003331 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-857341 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3458439 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3891047 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58436502 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14176520 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11109383 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-17177333 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-3382000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2948000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-240077000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-19056000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-265463138 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-7153000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6573000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-5631000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-20094000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
29035481 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
212806849 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
39129144 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-23516181 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5638000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4747000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-181728000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-17554000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-209667014 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5040000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4333000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3628000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-17952000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-30953266 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4473137 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1232952 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
507376 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
761064 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
734360 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1237385 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
64600000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1262720 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1982223 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2014Q4 us-gaap Other Liabilities
OtherLiabilities
405325 USD
CY2015Q4 us-gaap Other Liabilities
OtherLiabilities
332218 USD
CY2013 us-gaap Other Noncash Expense
OtherNoncashExpense
48774 USD
CY2014 us-gaap Other Noncash Expense
OtherNoncashExpense
31175 USD
CY2015 us-gaap Other Noncash Expense
OtherNoncashExpense
10052 USD
CY2013 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2014 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4000000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 USD
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
178952 USD
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
415940 USD
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
857341 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28046 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108953 USD
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
898705 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
623983 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7000000 USD
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
751370 USD
CY2013 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
569607 USD
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
569607 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
-2868387 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102035 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12200 USD
CY2014 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
223949 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4329187 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3749242 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
831936 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449825 USD
CY2013 us-gaap Reorganization Items
ReorganizationItems
0 USD
CY2014 us-gaap Reorganization Items
ReorganizationItems
2126536 USD
CY2015 us-gaap Reorganization Items
ReorganizationItems
7811551 USD
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8000000 USD
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000001 USD
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13785083 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2813000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2372000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2742000 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2903000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10707354 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2811000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2959000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2427000 USD
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4933000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13130529 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4000000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2013 us-gaap Restructuring Charges
RestructuringCharges
512944 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-421991008 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-461442332 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13119029 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3039000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2748000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4314000 USD
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2423000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12646653 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3088000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2605000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2321000 USD
CY2015Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2568000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-246502477 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10582068 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2263506 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2435462 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1574038 USD
CY2010Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4500000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1724967 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.71
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
180599 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.34
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2115566 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1924967 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1914633 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.51
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y1M18D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y0M10D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y0M15D
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
28243002 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
16975468 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-284428550 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10900000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Explanation Of Change
ValuationAllowanceDeferredTaxAssetExplanationOfChange
53.5
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52368842 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53419686 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53777687 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52368842 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53419686 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53777687 shares
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has cash in bank accounts that exceed the Federal Deposit Insurance Corporation insured limits. The Company has not experienced any losses on its cash accounts and no allowance has been provided for potential credit losses because management believes that any such losses would be minimal, if any. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">As part of its chapter 11 case, on January 29, 2015, the Company established debtor-in-possession bank accounts </font><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:10pt;">DIP Accounts</font><font style="font-family:inherit;font-size:12pt;">&#8221;</font><font style="font-family:inherit;font-size:10pt;"> in accordance with the provisions of the Bankruptcy Code and transferred substantially all its cash into the DIP Accounts in February 2015.</font></div></div>
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and related disclosures are prepared in conformity with accounting principles generally accepted in the United States of America. Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the period reported. The most significant estimates include the variables used in the calculation of fair value of stock-based awards including options and warrants granted or issued by the Company; reported amounts of revenue; calculation of contingencies including estimating litigation accrual; and the realization of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0001010086-16-000019-index-headers.html Edgar Link pending
0001010086-16-000019-index.html Edgar Link pending
0001010086-16-000019.txt Edgar Link pending
0001010086-16-000019-xbrl.zip Edgar Link pending
exhibit101-01cmodification.htm Edgar Link pending
exhibit102-01cmodification.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20151231.xml Edgar Link completed
siga-20151231.xsd Edgar Link pending
siga-20151231x10k.htm Edgar Link pending
siga-20151231_cal.xml Edgar Link unprocessable
siga-20151231_def.xml Edgar Link unprocessable
siga-20151231_lab.xml Edgar Link unprocessable
siga-20151231_pre.xml Edgar Link unprocessable
siga-201512_chartx28023.jpg Edgar Link pending
siga-exhibit2312015ye.htm Edgar Link pending
siga-exhibit3112015ye.htm Edgar Link pending
siga-exhibit3122015ye.htm Edgar Link pending
siga-exhibit3212015ye.htm Edgar Link pending
siga-exhibit3222015ye.htm Edgar Link pending